Although the prevalence of diabetes-related eye diseases has almost doubled since 2014, the rates of the most severe forms of the disease have actually decreased, according to a new study led by ...

Absolute risk for nonarteritic anterior ischemic optic neuropathy remained low, however ...

While eye drops may help alleviate some symptoms of diabetic retinopathy, they don’t target the underlying blood vessel damage in your retina. Retinopathy is a possible complication of diabetes. At ...

Two-year Phase III data presented at ASRS 2024 show Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR) Safety data were ...

Blurry vision can be an early warning sign of diabetes. It's also a sign of advanced diabetic eye disease. If blood sugar goes uncontrolled, diabetes causes progressive damage to structures in the ...

Did you know that both type 1 and 2 diabetes can damage your eyes and cause vision loss? That’s right, the primary cause of blindness in adults ages 20-74 is diabetes. Damage can occur for years ...

Breakthrough research shows diabetes medicine metformin may reduce age-related vision loss by 37%. Liverpool study offers hope for AMD treatment.

November is Diabetes-related Eye Disease Awareness Month, and early detection and treatment of diabetes are key to reduce the risk for significant vision loss and blindness, according to Prevent ...

Continuous glucose monitoring (CGM) is associated with reduced risk of diabetic retinopathy and proliferative diabetic retinopathy in type 1 diabetes patients. Language barriers and limited health ...

Regular eye exams are important in detecting early signs of diabetic retinopathy to prevent vision loss. Since diabetic retinopathy doesn’t cause symptoms in its early stages, diagnostic testing can ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

– Two-year Phase III data presented at ASRS 2024 show Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR) – – Safety data were ...